Magnesium Toxicity Management

Clinical Presentation and Treatment

• ECG interval changes, such as prolonged PR, QRS, and QT intervals, occur at magnesium levels of 2.5-5 mmol/L, according to the American Heart Association, and are associated with cardiovascular manifestations of magnesium toxicity 1, 2
• AV nodal conduction block, bradycardia, and hypotension can occur at magnesium levels of 6-10 mmol/L, as reported by the American Heart Association, and are indicative of severe magnesium toxicity 1, 2
• Loss of tendon reflexes, sedation, severe muscular weakness, and respiratory depression can occur at magnesium levels of 4-5 mmol/L, as noted by the American Heart Association, and are characteristic of neurological manifestations of magnesium toxicity 1, 2
• Gastrointestinal symptoms, such as nausea and vomiting, can occur in patients with magnesium toxicity, as reported by the American Heart Association 1, 2
• Electrolyte and fluid abnormalities, including hypophosphatemia and hyperosmolar dehydration, can occur in patients with magnesium toxicity, as noted by the American Heart Association 1, 2
• Patients with renal impairment can develop toxicity after relatively lower magnesium doses, and require careful monitoring, as recommended by the American Heart Association 1, 2
• Iatrogenic overdose is possible in pregnant women receiving magnesium sulfate for preeclampsia or eclampsia, particularly if the woman becomes oliguric, and requires careful attention to maternal and fetal monitoring, as reported by the American Heart Association 1, 2
• Continuing magnesium administration when oliguria develops, especially in pregnant women, can increase the risk of toxicity, as noted by the American Heart Association 1, 2

Treatment for Magnesium Sulfate Poisoning

Clinical Presentation and Treatment

• The American Heart Association recommends immediate administration of intravenous calcium (calcium chloride 10% 5-10 mL or calcium gluconate 10% 15-30 mL IV over 2-5 minutes) for magnesium sulfate poisoning, as it acts as a physiological antagonist to magnesium 3, 4
• Hypermagnesemia is defined as a serum magnesium concentration >2.2 mEq/L, and can cause neurological symptoms such as muscular weakness, paralysis, ataxia, drowsiness, and confusion 3
• The American College of Cardiology recommends continuous cardiac monitoring for arrhythmias, as cardiovascular manifestations of magnesium toxicity include vasodilation, hypotension, bradycardia, and cardiac arrhythmias 3, 4
• Correction of any other electrolyte abnormalities, particularly potassium, is crucial in the treatment of magnesium sulfate poisoning, according to the American College of Cardiology 4
• Blood pressure support with vasopressors may be necessary if hypotension persists despite calcium administration and fluid resuscitation, as recommended by the American Heart Association 3
• The American Heart Association and the American College of Cardiology recommend delaying calcium administration while waiting for laboratory confirmation of hypermagnesemia when clinical signs strongly suggest magnesium toxicity is a common pitfall to avoid 3, 4
• The American College of Cardiology recommends that in pregnant patients with preeclampsia who received therapeutic magnesium sulfate, the same principles of treatment apply, but with careful attention to maternal and fetal monitoring 5, 6

Management of Magnesium Sulfate Toxicity

Clinical Manifestations and Management

• The American Heart Association recommends empirical calcium administration (calcium chloride 10% 5-10 mL or calcium gluconate 10% 15-30 mL IV over 2-5 minutes) as a lifesaving measure when magnesium toxicity is suspected, without delaying for laboratory confirmation 7
• ECG changes, including prolonged PR, QRS, and QT intervals, loss of deep tendon reflexes, flushing and sweating, and nausea and vomiting, are clinical manifestations of mild-moderate toxicity (2.5-5 mmol/L) 7
• Severe toxicity (4-10 mmol/L) is characterized by sedation and severe muscular weakness, respiratory depression, AV nodal conduction block and bradycardia, and hypotension 7
• In cases of iatrogenic overdose, particularly in oliguric pregnant women receiving magnesium for preeclampsia, careful monitoring and management are crucial 7, 8
• The American College of Cardiology suggests that patients with renal impairment develop toxicity at relatively lower doses, and recommends maximum dose, serum creatinine check, and frequent serum magnesium monitoring 7